Plain-English translation of NCT07173868 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing whether a specialized imaging scan called F-18 FDG PET-CT is better than standard CT scans at showing how well treatment is working in advanced breast cancer. Researchers want to understand if this imaging method can predict treatment outcomes more accurately and help doctors make better decisions about your care.
When breast cancer has spread or cannot be surgically removed, doctors need reliable ways to know if treatment is working. Current imaging methods sometimes struggle to accurately show treatment response, especially when cancer has spread to the liver or bones. This study aims to find a better imaging method to guide treatment decisions.
You likely qualify if…
You likely don't qualify if…
You would have imaging scans before starting treatment and then again at 6, 12, 24, and 48 weeks during treatment. These scans include a specialized PET-CT scan and a contrast-enhanced CT scan, with possible bone scans if needed. Some participants may also have blood samples collected at the same time points to measure cancer markers in the bloodstream.
AI-generated summary from trial data · Jun 27, 2026 · Not medical advice
South Korea